Roth Still Loves Galmed Pharma, Keeps $20 Price Target And 'Buy' Rating
July 08, 2015 at 21:26 PM EDT
Shares of Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) fell 3.34 percent on Wednesday, after the company announced the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.